Advanced left-atrial fibrosis is associated with unsuccessful maze operation for valvular atrial fibrillation

European Journal of Cardio-thoracic Surgery

Volumn 40, Issue 1, 2011, Pages 61-69

  Kainuma, Satoshi ^a   Masai, Takafumi ^a   Yoshitatsu, Masao ^a   Miyagawa, Shigeru ^a   Yamauchi, Takashi ^a   Takeda, Koji ^a   Morii, Eiichi ^b   Sawa, Yoshiki ^b  

^a Sakurabashi Watanabe Hospital   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Atrial fibrillation; Atrial remodeling; Fibrosis; Maze operation

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CELL SIZE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEART ATRIUM FIBRILLATION; HEART ATRIUM HYPERTROPHY; HEART LEFT ATRIUM; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART VALVE SURGERY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LEFT ATRIUM FIBROSIS; MALE; MAZE OPERATION; MITRAL VALVE STENOSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SINUS RHYTHM; SURGICAL PATIENT; TREATMENT OUTCOME;

AGED; ATRIAL FIBRILLATION; CHRONIC DISEASE; FEMALE; FIBROSIS; FOLLOW-UP STUDIES; HEART ATRIA; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; MITRAL VALVE STENOSIS; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 79958019216     PISSN: 10107940     EISSN: 1873734X     Source Type: Journal    
DOI: 10.1016/j.ejcts.2010.11.008     Document Type: Article

References (22)

1. Chesebro J.H., Fuster V., Halperin J.L. Atrial fibrillation: risk marker for stroke. N Engl J Med 1990, 323:1556-1558.
2. Benjamin E.J., Wolf P.A., D'Agostino R.B., Silbershatz H., Kannel W.B., Levy D. Impact of atrial fibrillation on the risk of death: the Framingham heart study. Circulation 1998, 98:946-952.
3. Cox J.L., Jaquiss R.D., Schuessler R.B., Boineau J.P. Modification of the maze procedure for atrial flutter and atrial fibrillation: II. Surgical technique of the maze III procedure. J Thorac Cardiovasc Surg 1995, 110:485-495.
4. Stulak J.M., Sundt T.M., Dearani J.A., Daly R.C., Orsulak T.A., Schaff H.V. Ten-year experience with the Cox-maze procedure for atrial fibrillation: how do we define success?. Ann Thorac Surg 2007, 83:1319-1324.
5. Kobayashi J., Kosakai Y., Nakano K., Sasako Y., Eishi K., Yamamoto F. Improved success rate of the maze procedure in mitral valve disease by new criteria for patients' selection. Eur J Cardiothorac Surg 1998, 13:247-252.
6. Gaynor S.L., Schuessler R.B., Bailey M.S., Ishii Y., Boineau J.P., Gleva M.J., Cox J.L., Damiano R.J. Surgical treatment of atrial fibrillation: predictors of late recurrence. J Thorac Cardiovasc Surg 2005, 129:104-111.
7. Gillinov A.M., Sirak J., Blackstone E.H., McCarthy P.M., Rajeswaran J., Pettersson G., Sabik F.J., Svensson L.G., Navia J.L., Cosgrove D.M., Marrouche N., Natale A. The Cox maze procedure in mitral valve disease: predictors of recurrent atrial fibrillation. J Thorac Cardiovasc Surg 2005, 130:1653-1660.
8. Boldt A., Wetzel U., Lauschke J., Weigl J., Gummert J., Hindricks G., Kottkamp H., Dhein S. Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart 2004, 90:400-405.
9. Allessie M., Ausma J., Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc Res 2002, 54:230-246.
10. Todd D.M., Skanes A.C., Guiraudon G., Guiraudon C., Krahn A.D., Yee R., Klein G.J. Role of the posterior left atrium and pulmonary veins in human lone atrial fibrillation: electrophysiological and pathological data from patients undergoing atrial fibrillation surgery. Circulation 2003, 108:3108-3114.
11. Corradi D., Callegari S., Benussi S., Maestri R., Pastori P., Nascimbene S., Bosio S., Dorigo E., Grassani C., Rusconi R., Vettori M.V., Alinovi R., Astorri E., Pappone C., Alfieri O. Myocyte changes and their left atrial distribution in patients with chronic atrial fibrillation related to mitral valve disease. Hum Pathol 2005, 36:1080-1089.
12. Anné W., Willems R., Roskams T., Sergeant P., Herijgers P., Holemans P., Ector H., Heidbüchel H. Matrix metalloproteinases and atrial remodeling in patients with mitral valve disease and atrial fibrillation. Cardiovasc Res 2005, 67:655-666.
13. Saito T., Tamura K., Uchida D., Saito T., Togashi M., Nitta T., Sugisaki Y. Histopathological features of the resected left atrial appendage as predictors of recurrence after surgery for atrial fibrillation in valvular heart disease. Circ J 2007, 71:70-78.
14. Li D., Fareh S., Leung T.K., Nattel S. Promotion of atrial fibrillation by heart failure in dogs: atrial remodeling of a different sort. Circulation 1999, 100:87-95.
15. Allessie M.A., Boyden P.A., Camm A.J., Kléber A.G., Lab M.J., Legato M.J., Rosen M.R., Schwartz P.J., Spooner P.M., Van Wagoner D.R., Waldo A.L. Pathophysiology and prevention of atrial fibrillation. Circulation 2001, 103:769-777.
16. Stulak J.M., Schaff H.V., Dearani J.A., Orszulak T.A., Daly R.C., Sundt T.M. Restoration of sinus rhythm by the Maze procedure halts progression of tricuspid regurgitation after mitral surgery. Ann Thorac Surg 2008, 86(July (1)):40-44.
17. Matsuyama K., Matsumoto M., Sugita T., Nishizawa J., Tokuda Y., Matsuo T. Predictors of residual tricuspid regurgitation after mitral valve surgery. Ann Thorac Surg 2003, 75:1826-1828.
18. Goette A., Staack T., Rocken C., Arndt M., Geller J.C., Huth C., Ansorge S., Klein H.U., Lendeckel U. Increased expression of extracellular signal-regulated kinase and angiotensin converting enzyme in human atria during atrial fibrillation. J Am Coll Cardiol 2000, 35:1669-1677.
19. Li D., Shinagawa K., Pang L., Leung T.K., Cardin S., Wang Z., Nattel S. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure. Circulation 2001, 104:2608-2614.
20. Kumagai K., Nakashima H., Urata H., Gondo N., Arakawa K., Saku K. Effects of angiotensin II type 1 receptor antagonist on electrical and structural remodeling in atrial fibrillation. J Am Coll Cardiol 2003, 41:2197-2204.
21. Nakashima H., Kumagai K., Urata H., Gondo N., Ideishi M., Arakawa K. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation. Circulation 2000, 101:2612-2617.
22. Corradi D., Callegari S., Benussi S., Nascimbene S., Pastori P., Calvi S., Maestri R., Astorri E., Pappone C., Alfieri O. Regional left atrial interstitial remodeling in patients with chronic atrial fibrillation undergoing mitral-valve surgery. Virchows Arch 2004, 445:498-505.